1397 related articles for article (PubMed ID: 26757051)
21. High-Throughput
Westhaus A; Cabanes-Creus M; Rybicki A; Baltazar G; Navarro RG; Zhu E; Drouyer M; Knight M; Albu RF; Ng BH; Kalajdzic P; Kwiatek M; Hsu K; Santilli G; Gold W; Kramer B; Gonzalez-Cordero A; Thrasher AJ; Alexander IE; Lisowski L
Hum Gene Ther; 2020 May; 31(9-10):575-589. PubMed ID: 32000541
[TBL] [Abstract][Full Text] [Related]
22. Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution.
Grimm D; Büning H
Hum Gene Ther; 2017 Nov; 28(11):1075-1086. PubMed ID: 28835125
[TBL] [Abstract][Full Text] [Related]
23. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.
Shayakhmetov DM; Carlson CA; Stecher H; Li Q; Stamatoyannopoulos G; Lieber A
J Virol; 2002 Feb; 76(3):1135-43. PubMed ID: 11773389
[TBL] [Abstract][Full Text] [Related]
24. High-Throughput Quantification of
Xu M; Li J; Xie J; He R; Su Q; Gao G; Tai PWL
Hum Gene Ther; 2019 Aug; 30(8):946-956. PubMed ID: 31072208
[TBL] [Abstract][Full Text] [Related]
25. Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration.
Wang Y; Camp SM; Niwano M; Shen X; Bakowska JC; Breakefield XO; Allen PD
J Virol; 2002 Jul; 76(14):7150-62. PubMed ID: 12072515
[TBL] [Abstract][Full Text] [Related]
26. Adeno-associated Virus (AAV) Assembly-Activating Protein Is Not an Essential Requirement for Capsid Assembly of AAV Serotypes 4, 5, and 11.
Earley LF; Powers JM; Adachi K; Baumgart JT; Meyer NL; Xie Q; Chapman MS; Nakai H
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852862
[TBL] [Abstract][Full Text] [Related]
27. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.
Koo T; Popplewell L; Athanasopoulos T; Dickson G
Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945
[TBL] [Abstract][Full Text] [Related]
28. Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences.
Aurnhammer C; Haase M; Muether N; Hausl M; Rauschhuber C; Huber I; Nitschko H; Busch U; Sing A; Ehrhardt A; Baiker A
Hum Gene Ther Methods; 2012 Feb; 23(1):18-28. PubMed ID: 22428977
[TBL] [Abstract][Full Text] [Related]
29. Single-Cell Quantification of Triple-AAV Vector Genomes Coexpressed in Neurons.
Maturana CJ; Verpeut JL; Engel EA
Curr Protoc; 2022 May; 2(5):e430. PubMed ID: 35616444
[TBL] [Abstract][Full Text] [Related]
30. Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions.
Wang XS; Ponnazhagan S; Srivastava A
J Virol; 1996 Mar; 70(3):1668-77. PubMed ID: 8627687
[TBL] [Abstract][Full Text] [Related]
31. Recombinant adeno-associated virus as delivery vector for gene therapy--a review.
Lu Y
Stem Cells Dev; 2004 Feb; 13(1):133-45. PubMed ID: 15068701
[TBL] [Abstract][Full Text] [Related]
32. Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation.
Wang Y; Ling C; Song L; Wang L; Aslanidi GV; Tan M; Ling C; Srivastava A
Hum Gene Ther Methods; 2012 Aug; 23(4):225-33. PubMed ID: 22966785
[TBL] [Abstract][Full Text] [Related]
33. Adeno-associated virus-based vectors in gene therapy.
Tal J
J Biomed Sci; 2000; 7(4):279-91. PubMed ID: 10895050
[TBL] [Abstract][Full Text] [Related]
34. Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid.
Martino RA; Wang Q; Xu H; Hu G; Bell P; Arroyo EJ; Sims JJ; Wilson JM
J Virol; 2023 Jun; 97(6):e0017423. PubMed ID: 37199615
[TBL] [Abstract][Full Text] [Related]
35. Second generation adeno-associated virus type 2-based gene therapy systems with the potential for preferential integration into AAVS1.
Owens RA
Curr Gene Ther; 2002 May; 2(2):145-59. PubMed ID: 12109212
[TBL] [Abstract][Full Text] [Related]
36. AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence.
Wang Z; Lisowski L; Finegold MJ; Nakai H; Kay MA; Grompe M
Mol Ther; 2012 Oct; 20(10):1902-11. PubMed ID: 22990673
[TBL] [Abstract][Full Text] [Related]
37. Design of AAV Vectors for Delivery of Large or Multiple Transgenes.
Patel A; Zhao J; Duan D; Lai Y
Methods Mol Biol; 2019; 1950():19-33. PubMed ID: 30783966
[TBL] [Abstract][Full Text] [Related]
38. Effect of genome size on AAV vector packaging.
Wu Z; Yang H; Colosi P
Mol Ther; 2010 Jan; 18(1):80-6. PubMed ID: 19904234
[TBL] [Abstract][Full Text] [Related]
39. Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers.
Yan Z; Sun X; Feng Z; Li G; Fisher JT; Stewart ZA; Engelhardt JF
Hum Gene Ther; 2015 Jun; 26(6):334-46. PubMed ID: 25763813
[TBL] [Abstract][Full Text] [Related]
40. Adeno-associated virus (AAV) vectors in cancer gene therapy.
Santiago-Ortiz JL; Schaffer DV
J Control Release; 2016 Oct; 240():287-301. PubMed ID: 26796040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
